Jazz Pharmaceuticals plcJazz Pharmaceuticals plcJazz Pharmaceuticals plc

Jazz Pharmaceuticals plc

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.85 B‬USD
‪414.83 M‬USD
‪3.83 B‬USD
‪61.02 M‬
Beta (1Y)
0.42

About Jazz Pharmaceuticals plc

CEO
Bruce C. Cozadd
Headquarters
Dublin
Employees (FY)
‪2.8 K‬
Founded
2005
ISIN
IE00B4Q5ZN47
FIGI
BBG000G9CGL0
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of JAZZ is 106.97 USD — it has decreased by 1.52% in the past 24 hours. Watch Jazz Pharmaceuticals plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jazz Pharmaceuticals plc stocks are traded under the ticker JAZZ.
JAZZ stock has fallen by 6.13% compared to the previous week, the month change is a 2.10% fall, over the last year Jazz Pharmaceuticals plc has showed a 20.39% decrease.
We've gathered analysts' opinions on Jazz Pharmaceuticals plc future price: according to them, JAZZ price has a max estimate of 230.00 USD and a min estimate of 117.00 USD. Watch JAZZ chart and read a more detailed Jazz Pharmaceuticals plc stock forecast: see what analysts think of Jazz Pharmaceuticals plc and suggest that you do with its stocks.
JAZZ reached its all-time high on Jul 31, 2015 with the price of 194.73 USD, and its all-time low was 0.52 USD and was reached on Apr 22, 2009. View more price dynamics on JAZZ chart.
See other stocks reaching their highest and lowest prices.
JAZZ stock is 1.87% volatile and has beta coefficient of 0.42. Track Jazz Pharmaceuticals plc stock price on the chart and check out the list of the most volatile stocks — is Jazz Pharmaceuticals plc there?
Today Jazz Pharmaceuticals plc has the market capitalization of ‪6.85 B‬, it has decreased by 1.09% over the last week.
Yes, you can track Jazz Pharmaceuticals plc financials in yearly and quarterly reports right on TradingView.
Jazz Pharmaceuticals plc is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
JAZZ earnings for the last quarter are 2.68 USD per share, whereas the estimation was 4.18 USD resulting in a −35.87% surprise. The estimated earnings for the next quarter are 4.74 USD per share. See more details about Jazz Pharmaceuticals plc earnings.
Jazz Pharmaceuticals plc revenue for the last quarter amounts to ‪901.98 M‬ USD despite the estimated figure of ‪953.97 M‬ USD. In the next quarter revenue is expected to reach ‪1.00 B‬ USD.
JAZZ net income for the last quarter is ‪−14.62 M‬ USD, while the quarter before that showed ‪94.15 M‬ USD of net income which accounts for −115.53% change. Track more Jazz Pharmaceuticals plc financial stats to get the full picture.
No, JAZZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 22, 2024, the company has ‪2.80 K‬ employees. See our rating of the largest employees — is Jazz Pharmaceuticals plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Jazz Pharmaceuticals plc EBITDA is ‪1.25 B‬ USD, and current EBITDA margin is 33.85%. See more stats in Jazz Pharmaceuticals plc financial statements.
Like other stocks, JAZZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jazz Pharmaceuticals plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jazz Pharmaceuticals plc technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jazz Pharmaceuticals plc stock shows the sell signal. See more of Jazz Pharmaceuticals plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.